Code	Sector	Market
4893	Pharmaceuticals	Growth

Date of listing approval	2023/05/25
Expected Date	2023/06/28
Lead Underwriter	SMBC Nikko
Description

Listed Shares(total)	4,166,400
Trading Unit	100
New Shares	3,623,000
Existing Shares	543,400（only O.A.）
Shares Outstanding	PreIPO 39,579,865.00
	PostIPO 43,202,865.00
Paid Up Capital	PreIPO Y2,787,552,000
	PostIPO Y3,134,419,600
Expected Pricing Date	2023/06/12
Book Building Start	2023/06/13
Book Building End	2023/06/16
Fix Date	2023/06/19
Offering Starts	2023/06/20
Offering Ends	2023/06/23
Expect Pricing	Y700-Y740
Notional PER (based on previous period)	-70.92--74.97
Notional PER(based on results forecast)	-15.81--16.72
Offering Price	Y740
Offering Price PER (based on previous period)	-15.81--16.72
Offering Price PBR (based on previous period)	6.82
Offering Price PER (based on results forecast)	-16.72
Use of Funds Raised

Units:Y1,000

Fiscal Year End:2020/12
	Consolidated	Non-consolidated
Revenue	-	97,277
Current Profit	-	-604,610
Net Profit	-	-636,649
Net Assets	-	2,598,379

Fiscal Year End:2021/12
	Consolidated	Non-consolidated
Revenue	-	100,732
Current Profit	-	-792,615
Net Profit	-	-795,035
Net Assets	-	4,185,334

Fiscal Year End:2022/12
	Consolidated	Non-consolidated
Revenue	-	625,783
Current Profit	-	-384,202
Net Profit	-	-386,622
Net Assets	-	4,300,617

Recent Quarter 2023/03
	Consolidated	Non-consolidated
Revenue	-	8,101
Current Profit	-	-493,787
Net Profit	-	-494,395
Net Assets	-	3,806,221

Results Forecast 2023/12
	Consolidated	Non-consolidated
Revenue	-	319,000
Current Profit	-	-1,832,000
Net Profit	-	-1,834,000
Net Assets	-	-

Per Share Units:Y1

Fiscal Year End:2020/12
	Consolidated	Non-consolidated
Dividend	0.00
Net Earning	-	-
Equity	-17.93	72.24

Fiscal Year End:2021/12
	Consolidated	Non-consolidated
Dividend	0.00
Net Earning	-	-
Equity	-20.75	107.30

Fiscal Year End:2022/12
	Consolidated	Non-consolidated
Dividend	0.00
Net Earning	-	-
Equity	-9.87	108.48

Fiscal Year End:Recent Quarter 2023/03
	Consolidated	Non-consolidated
Dividend
Net Earning	-	-12.49
Equity	-	-

Fiscal Year End:Results Forecast 2023/12
	Consolidated	Non-consolidated
Dividend	0.00
Net Earning	-	-44.27
Equity	-	-

■Over allotment(543,400)

Name	Address

Allocation	Underwriter	Tel
0%	Nomura	03-3211-1811
80.1%	SMBC Nikko	03-5644-3111
8%	SBI SECURITIES Co.,Ltd.	03-5562-7210
4.2%	Nomura	03-3211-1811
4.2%	Mizuho	03-5208-3210
0.5%	Toyo	03-5117-1040
0.5%	IwaiCosmo Securities Co.,Ltd.	06-6229-2890
0.5%	Akatsuki Securities	03-5641-7800
0.5%	Marusan	03-3272-5211
0.5%	Kyokuto	03-3667-9171
0.5%	Monex	03-4323-3800
0.5%	Okasan	03-3272-2211